Sight Sciences News and Activities

Sight Sciences is a company listed under the stock ticker SGHT (US).

View the org chart displaying its 25 main executives

Most searched biographies at Sight Sciences

• Paul Badawi, Chief Executive Officer and Director
• Staffan Encrantz, Director
• Donald Zurbay, Director

Popular executive movements at Sight Sciences

• Jim Rodberg, who was Vice President, Finance, is promoted to Chief Financial Officer  (posted on November 7 2025).
• Erica Rogers, Director, has left the company  (posted on November 7 2025).
• Brenda Becker, Director, has left the company  (posted on November 7 2025).

Click here to view some more movements at Sight Sciences

Create your alert
to follow the executive moves at Sight Sciences.

Sight Sciences has 2,405 competitors including Eurofins (Luxembourg), Lonza (Switzerland) and BioNTech (Germany).

Popular M&A news in Biotechnology

• IMU Biosciences has just announced a $53 Million fundraising (posted on June 3 2026).
• NewLimit has just announced a $435 Million fundraising (posted on June 3 2026).
• Rallybio and Avenzo Therapeutics have announced they will merge  (posted on June 1 2026)..

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Valerie Hanote - Non-Executive Director at Eurofins

Learn more about the Biotechnology industry

Press releases by Sight Sciences

• News Archives
• Sight Sciences Announces Publication of a New Analysis from The ROMEO Study Showing Meaningful Pressure and Medication Reductions Achieved with OMNI® Across Mild, Moderate, and Advanced Glaucoma
• News Archives
• News Archives - Page 8 of 8 - International
• News Archives - Page 7 of 7 - International
• News Archives - Page 6 of 6 - International
• View more press releases Close

Social media about Sight Sciences

• Sight Sciences on Wikipedia, Google News & Yahoo Finance
• Sight Sciences on LinkedIn, X (Twitter) & YouTube